Stock DNA
Chemicals & Petrochemicals
CNY 21,018 Million (Large Cap)
NA (Loss Making)
NA
0.00%
0.11
-1.02%
1.13
Revenue and Profits:
Net Sales:
1,388 Million
(Quarterly Results - Mar 2026)
Net Profit:
172 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.44%
0%
18.44%
6 Months
25.65%
0%
25.65%
1 Year
66.09%
0%
66.09%
2 Years
36.32%
0%
36.32%
3 Years
8.24%
0%
8.24%
4 Years
-7.07%
0%
-7.07%
5 Years
62.36%
0%
62.36%
Sichuan Hebang Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.42%
EBIT Growth (5y)
-181.26%
EBIT to Interest (avg)
33.91
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
0.36
Tax Ratio
2.14%
Dividend Payout Ratio
526.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.99%
ROE (avg)
9.56%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.91
EV to EBIT
-80.08
EV to EBITDA
25.14
EV to Capital Employed
0.92
EV to Sales
2.48
PEG Ratio
NA
Dividend Yield
1.05%
ROCE (Latest)
-1.15%
ROE (Latest)
-1.18%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,387.80
1,261.00
10.06%
Operating Profit (PBDIT) excl Other Income
236.10
-420.80
156.11%
Interest
28.70
39.00
-26.41%
Exceptional Items
0.00
-60.30
100.00%
Consolidate Net Profit
172.30
-789.10
121.84%
Operating Profit Margin (Excl OI)
170.10%
-544.40%
71.45%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 10.06% vs -37.12% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 121.84% vs -2,279.83% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
7,182.00
8,538.00
-15.88%
Operating Profit (PBDIT) excl Other Income
873.10
938.20
-6.94%
Interest
124.90
66.90
86.70%
Exceptional Items
-389.00
1.00
-39,000.00%
Consolidate Net Profit
-712.70
-70.70
-908.06%
Operating Profit Margin (Excl OI)
-19.50%
-6.30%
-1.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -15.88% vs -2.51% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -908.06% vs -105.53% in Dec 2024
About Sichuan Hebang Biotechnology Co., Ltd. 
Sichuan Hebang Biotechnology Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






